TITLE

HIV Breastfeeding Recommendations

PUB. DATE
June 2010
SOURCE
BioWorld Today;6/21/2010, Vol. 21 Issue 118, Special section p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on a study, which showed the effectiveness of antiretroviral drug intake among human immunodeficiency virus (HIV)-infected breastfeeding mothers and HIV-fighting syrup for their babies in the prevention of HIV infection.
ACCESSION #
51546510

 

Related Articles

  • Pre-Exposure Prophylaxis for HIV. Maynard, Tony // HIV Australia;Jul-Sep2005, Vol. 5 Issue 1, p23 

    Provides information on pre-exposure prophylaxis (PREP) for HIV which involves HIV negative people using antiretrovirals prior to engaging in activities that may lead to HIV transmission such as unprotected sex. Information on clinical trials to prove that using PREP could prevent infection;...

  • Vaginal gel may help prevent HIV.  // Contemporary Sexuality;Sep2010, Vol. 44 Issue 9, p6 

    This article reports on a study of vaginal gels that contain the antiretroviral drug tenofovir and whether they can help prevent human immunodeficiency virus (HIV).

  • Studies confirm ART prevented HIV in uninfected heterosexual partners. Henry, Jennifer // Infectious Disease News;Aug2011, Vol. 24 Issue 8, p1 

    The article discusses two clinical trials which concluded that once-daily antiretroviral therapy may reduce the risk for HIV infection among uninfected men and women who were exposed to HIV through heterosexual sex with an infected partner.

  • Early Use of Antiretrovirals May Reduce HIV Transmission. Norman, Kayda // Applied Clinical Trials;Jun2011, Vol. 20 Issue 6, p17 

    The article discusses the findings of a study on a clinical trial known as the HPTN 052 in relation to the early use of oral antiretroviral therapy (ART). It states that the early use of ART may reduce the likelihood that a person with human immunodeficiency virus (HIV) will pass the virus to...

  • HPTN 071 (PopART): A Cluster-Randomized Trial of the Population Impact of an HIV Combination Prevention Intervention Including Universal Testing and Treatment: Mathematical Model. Cori, Anne; Ayles, Helen; Beyers, Nulda; Schaap, Ab; Floyd, Sian; Sabapathy, Kalpana; Eaton, Jeffrey W.; Hauck, Katharina; Smith, Peter; Griffith, Sam; Moore, Ayana; Donnell, Deborah; Vermund, Sten H.; Fidler, Sarah; Hayes, Richard; Fraser, Christophe // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: The HPTN 052 trial confirmed that antiretroviral therapy (ART) can nearly eliminate HIV transmission from successfully treated HIV-infected individuals within couples. Here, we present the mathematical modeling used to inform the design and monitoring of a new trial aiming to test...

  • Effectiveness of ART and Condom Use for Prevention of Sexual HIV Transmission in Serodiscordant Couples: A Systematic Review and Meta-Analysis. Liu, Huixin; Su, Yingying; Zhu, Lin; Xing, Jiannan; Wu, Jing; Wang, Ning // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Background: Consistent and correct condom use and suppressive antiretroviral therapy for the infected partner are two of the primary strategies recommended for prevention of heterosexual HIV transmission in serodiscordant couples today. The applied effectiveness of treatment as a prevention...

  • Characteristics of HIV-1 Serodiscordant Couples Enrolled in a Clinical Trial of Antiretroviral Pre-Exposure Prophylaxis for HIV-1 Prevention. Mujugira, Andrew; Baeten, Jared M.; Donnell, Deborah; Ndase, Patrick; Mugo, Nelly R.; Barnes, Linda; Campbell, James D.; Wangisi, Jonathan; Tappero, Jordan W.; Bukusi, Elizabeth; Cohen, Craig R.; Katabira, Elly; Ronald, Allan; Tumwesigye, Elioda; Were, Edwin; Fife, Kenneth H.; Kiarie, James; Farquhar, Carey; John-Stewart, Grace; Kidoguchi, Lara // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Introduction: Stable heterosexual HIV-1 serodiscordant couples in Africa have high HIV-1 transmission rates and are a critical population for evaluation of new HIV-1 prevention strategies. The Partners PrEP Study is a randomized, double-blind, placebo-controlled trial of tenofovir and...

  • Challenges and potential barriers to the uptake of antiretroviral-based prevention in Asia and the Pacific region. Ying-Ru Lo; Masaya Kato; Nittaya Phanuphak; Masami Fujita; Duong Bui Duc; Seng Sopheap; Pendse, Razia; Dongbao Yu; Zunyou Wu; Chariyalertsak, Suwat // Sexual Health (14485028);2014, Vol. 11 Issue 2, p126 

    Evidence has emerged over the past few years on the effectiveness of antiretroviral-based prevention technologies to prevent (i) HIV transmission while decreasing morbidity and mortality in HIV-infected persons, and (ii) HIV acquisition in HIV-uninfected individuals through pre-exposure...

  • The end of HIV: how do we get there? Pinto, Angie N.; Cooper, David // Medical Journal of Australia;7/21/2014, Vol. 201 Issue 2, p77 

    A letter to the editor is presented in response to article "HPTN 052 Study Team. Prevention of HIV-1 Infection With Early Antiretroviral Therapy" by M.S. Cohen and colleagues in the Volume 365, 2011 issue.

  • 'Getting to zero' in Asia and the Pacific through more strategic use of antiretrovirals for HIV prevention. Cassell, Michael M.; Holtz, Timothy H.; Wolfe, Mitchell I.; Hahn, Michael; Prybylski, Dimitri // Sexual Health (14485028);2014, Vol. 11 Issue 2, p107 

    Encouraged by experimental trials demonstrating the efficacy of antiretrovirals (ARVs) in preventing HIV infection, countries across the Asia-Pacific region have committed to the achievement of ambitious targets tantamount to ending AIDS. The available data suggest that some countries still can...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics